Abstract
For decades, a low-dose irradiation with X-rays has clinically been documented to exert a beneficial effect on hyperproliferative disorders like the Dupuytren disease (DD) and Ledderhose disease (LD). By contrast, experimental studies to unravel underlying cellular and molecular mechanisms are still at their early stages. Recent data, however, indicate the involvement of radiation-sensitive target cells like mitotic fibroblasts/myofibroblasts, induction of free radicals to impair proliferative activity of these cells, interference with growth factors and cytokines and a reduction of activated immune cells interacting with the inflammatory and proliferative processes. We here aim at briefly describing mechanisms contributing to a modulation of fibrogenic and inflammatory components upon exposure to ionizing radiation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abraham DJ, Eckes B, Rajkumar V, Krieg T (2007) New developments in fibroblast and myofibroblast biology: implications for fibrosis and scleroderma. Curr Rheumatol Rep 9(2):136–143
Alioto RJ, Rosier RN, Burton RI, Puzas JE (1994) Comparative effects of growth factors on fibroblasts of Dupuytren’s tissue and normal palmar fascia. J Hand Surg Am 19(3):442–452
Alman BA, Naber SP, Terek RM et al (1995) Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res 13(1):67–77
Andrew JG, Andrew SM, Ash A, Turner B (1991) An investigation into the role of inflammatory cells in Dupuytren’s disease. J Hand Surg Br 16(3):267–271
Badalamente MA, Sampson SP, Hurst LC et al (1996) The role of transforming growth factor beta in Dupuytren’s disease. J Hand Surg Am 21(2):210–215
Bayreuther K, Francz PI, Rodemann HP (1992) Fibroblasts in normal and pathological terminal differentiation, aging, apoptosis and transformation. Arch Gerontol Geriatr 15(Suppl 1):47–74
Bayreuther K, Rodemann HP, Francz PI, Maier K (1988a) Differentiation of fibroblast stem cells. J Cell Sci Suppl 10:115–130
Bayreuther K, Rodemann HP, Hommel R et al (1988b) Human skin fibroblasts in vitro differentiate along a terminal cell lineage. Proc Natl Acad Sci U S A 85(14):5112–5116
Berndt A, Kosmehl H, Katenkamp D, Tauchmann V (1994) Appearance of the myofibroblastic phenotype in Dupuytren’s disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 62(2):55–58
Bianchi E, Taurone S, Bardella L et al (2015) Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren’s contracture: a novel target for a possible future therapeutic strategy? Clin Sci (Lond) 129(8):711–720
Bumann J, Santo-Holtje L, Loffler H, Bamberg M, Rodemann HP (1995) Radiation-induced alterations of the proliferation dynamics of human skin fibroblasts after repeated irradiation in the subtherapeutic dose range. Strahlenther Onkol 171(1):35–41
Cordova A, Tripoli M, Corradino B et al (2005) Dupuytren’s contracture: an update of biomolecular aspects and therapeutic perspectives. J Hand Surg Br 30(6):557–562
Dolmans GH, Werker PM, Hennies HC et al (2011) Wnt signaling and Dupuytren’s disease. N Engl J Med 365(4):307–317
Fitzgerald AM, Kirkpatrick JJ, Naylor IL (1999) Dupuytren’s disease. The way forward? J Hand Surg Br 24(4):395–399
Gabbiani G, Ryan GB, Majne G (1971) Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27(5):549–550
Grenfell S, Borg M (2014) Radiotherapy in fascial fibromatosis: a case series, literature review and considerations for treatment of early-stage disease. J Med Imaging Radiat Oncol 58(5):641–647
Herskind C, Rodemann HP (2000) Spontaneous and radiation-induced differentiation of fibroblasts. Exp Gerontol 35(6–7):747–755, doi:S0531-5565(00)00168-6 [pii]
Hildebrandt G, Loppnow G, Jahns J et al (2003a) Inhibition of the iNOS pathway in inflammatory macrophages by low-dose X-irradiation in vitro. Is there a time dependence? Strahlenther Onkol 179(3):158–166
Hildebrandt G, Radlingmayr A, Rosenthal S et al (2003b) Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuvant-induced arthritis in rats. Int J Radiat Biol 79(12):993–1001
Hinz B, Phan SH, Thannickal VJ et al (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170(6):1807–1816
Iqbal SA, Hayton MJ, Watson JS et al (2014) First identification of resident and circulating fibrocytes in Dupuytren’s disease shown to be inhibited by serum amyloid P and Xiapex. PLoS One 9(6), e99967
Kern PM, Keilholz L, Forster C et al (2000) Low-dose radiotherapy selectively reduces adhesion of peripheral blood mononuclear cells to endothelium in vitro. Radiother Oncol 54(3):273–282
Kloen P, Jennings CL, Gebhardt MC et al (1995) Transforming growth factor-beta: possible roles in Dupuytren’s contracture. J Hand Surg Am 20(1):101–108
Krause C, Kloen P, Ten Dijke P (2011) Elevated transforming growth factor beta and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren’s disease fibroblasts. Fibrogenesis Tissue Repair 4(1):14
Lodermann B, Wunderlich R, Frey S et al (2012) Low dose ionising radiation leads to a NF-kappa B dependent decreased secretion of active IL-1 beta by activated macrophages with a discontinuous dose-dependency. Int J Radiat Biol 88(10):727–734
Meek RM, McLellan S, Crossan JF (1999) Dupuytren’s disease. A model for the mechanism of fibrosis and its modulation by steroids. J Bone Joint Surg Br 81(4):732–738
Meek RM, McLellan S, Reilly J, Crossan JF (2002) The effect of steroids on Dupuytren’s disease: role of programmed cell death. J Hand Surg Br 27(3):270–273
Murrell GA, Francis MJ, Bromley L (1987) Free radicals and Dupuytren’s contracture. Br Med J (Clin Res Ed) 295(6610):1373–1375
Murrell GA, Francis MJ, Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265(3):659–665
Nathan C, Cunningham-Bussel A (2013) Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. Nat Rev Immunol 13(5):349–361
Rehman S, Goodacre R, Day PJ, Bayat A, Westerhoff HV (2011) Dupuytren’s: a systems biology disease. Arthritis Res Ther 13(5):238
Richards SA, Muter J, Ritchie P, Lattanzi G, Hutchison CJ (2011) The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine. Hum Mol Genet 20(20):3997–4004
Robbins ME, Zhao W (2004) Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 80(4):251–259
Rödel F, Frey B, Capalbo G, Gaipl U, Keilholz L, Voll R, Hildebrandt G, Rodel C (2010) Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-kappaB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. Radiother Oncol 97(2):346–351
Rödel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US, Rodel C (2012) Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol 2:120
Rödel F, Frey B, Multhoff G, Gaipl U (2015) Contribution of the immune system to bystander and non-targeted effects of ionizing radiation. Cancer Lett 356(1):105–113
Rödel F, Kley N, Beuscher HU, Hildebrandt G, Keilholz L, Kern P, Voll R, Herrmann M, Sauer R (2002) Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion. Int J Radiat Biol 78(8):711–719
Rodemann HP, Bamberg M (1995) Cellular basis of radiation-induced fibrosis. Radiother Oncol 35(2):83–90
Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH (1991) Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 5(4):1135–1142; discussion 1142–1133
Rubin P, Soni A, Williams JP (1999) The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol 9(2):203–214
Rudolph R, Vande Berg J (1991) The myofibroblast in Dupuytren’s contracture. Hand Clin 7(4):683–692; discussion 693–684
Schaue D, Marples B, Trott KR (2002) The effects of low-dose X-irradiation on the oxidative burst in stimulated macrophages. Int J Radiat Biol 78(7):567–576
Seegenschmiedt MH, Makoski HB, Trott KR, Brady LWE (2008) Radiotherapy for non-malignant disorders. Medical radiology diagnostic imaging and radiation oncology. Springer, Berlin/Heidelberg
Seegenschmiedt MH, Micke O, Niewald M, Mucke R, Eich HT, Kriz J, Heyd R (2015) DEGRO guidelines for the radiotherapy of non-malignant disorders : part III: hyperproliferative disorders. Strahlenther Onkol 191(7):541–548
Shih B, Bayat A (2010) Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 6(12):715–726
Smitt MC, Donaldson SS (1999) Radiation therapy for benign disease of the orbit. Semin Radiat Oncol 9(2):179–189
Speyer CL, Ward PA (2011) Role of endothelial chemokines and their receptors during inflammation. J Invest Surg 24(1):18–27
Suit H, Spiro I (1999) Radiation treatment of benign mesenchymal disease. Semin Radiat Oncol 9(2):171–178
Travis EL (2001) Organizational response of normal tissues to irradiation. Semin Radiat Oncol 11(3):184–196
Tsukimoto M, Homma T, Mutou Y, Kojima S (2009) 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiat Res 171(2):219–224
Verjee LS, Verhoekx JS, Chan JK, Krausgruber T, Nicolaidou V, Izadi D, Davidson D, Feldmann M, Midwood KS, Nanchahal J (2013) Unraveling the signaling pathways promoting fibrosis in Dupuytren’s disease reveals TNF as a therapeutic target. Proc Natl Acad Sci U S A 110(10):E928–E937
Wong M, Mudera V (2006) Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren’s fibroblasts. J Hand Surg Br 31(5):473–483
Yarnold J, Brotons MC (2010) Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97(1):149–161
Zhao W, Robbins ME (2009) Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 16(2):130–143
Acknowledgements and Conflict of Interest Statement
This work has received funding from the European Atomic Energy Community’s Seventh Framework Programme under grant agreement no FP7-249689 (European Network of Excellence, DoReMi) and the German Federal Ministry of Education and Research (GREWIS, 02NUK017F). The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rödel, F., Seegenschmiedt, M.H. (2017). Introduction to Radiation Biology When Treating Hyperproliferative Benign Diseases. In: Werker, P., Dias, J., Eaton, C., Reichert, B., Wach, W. (eds) Dupuytren Disease and Related Diseases - The Cutting Edge. Springer, Cham. https://doi.org/10.1007/978-3-319-32199-8_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-32199-8_45
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32197-4
Online ISBN: 978-3-319-32199-8
eBook Packages: MedicineMedicine (R0)